Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO)

By Rau B.   Schlag P.M.   Willeke F.   Herfarth C.   Stephan P.   Franke W.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 992-998

Elsevier

Access to resources Recommend Favorite

Protection Against Cisplatin-Induced Nephrotoxicity by Recombinant Human Erythropoietin

By Yalcin Suayib   Müftüoùglu Sevda   Cetúõn Eren   Süarer Banu   Yildirim Berna Akkusü   Zeybek Dúõlara   Orhan Bülent  

Medical Oncology, Vol. 20, Iss. 2, 2003-06 ,pp. : 169-174

Humana Press, Inc

Access to resources Recommend Favorite

Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model

By Halteren H.   Bongaerts G.   Verhagen C.   Kamm Y.   Willems J.   Grutters G.   Koopman J.   Wagener D.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 4, 2004-04 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors

By Kondyli M.   Gatzounis G.   Kyritsis A.   Varakis J.   Assimakopoulou M.  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 157-164

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen Effect

By Silver D.F.   Piver M.S.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 280-284

Elsevier

Access to resources Recommend Favorite